Aim: The aim of this study was to undertake a systematic review of the literature and evaluate interventions used to improve continuity of medication management upon transition of care from an acute hospital setting to a residential aged care facility (RACF). Data sources: Embase, PubMed, The Cochrane Database of Systematic Reviews, Google Scholar, Informit Health Collection, grey literature and reference mining of included studies (from inception to March 2018). Study selection: Interventions aimed at improving the continuity of medication management upon discharge of patients from hospital to an RACF or similar facility were included. Interventions were defined as a communication tool or a service initiated by any healthcare professional. Studies were excluded if they were not available in English, had certain study designs (i.e. qualitative, observational and systematic review) and if no abstract and full-text article could be obtained. Results: Seven studies met the inclusion criteria. All interventions involved a multidisciplinary approach to discharge facilitation including the provision of discharge medication information. Six studies included pharmacist-led medication reconciliation. Two studies used an RACF-specific medication chart. Although positive findings were shown for most interventions, critical analysis of the studies included identified many limitations. Conclusion: Interventions involving a multidisciplinary team, pharmacist-led medication reconciliation and the provision of accurate discharge information have been identified as improving continuity of medication management during transitions of care from hospital to RACF. Importantly, this systematic review has identified an ongoing need for development of a comprehensive intervention that addresses all barriers to optimal continuity of medications encountered during this high-risk transition.
INTRODUCTION
Australia is currently facing the realities of an ageing population that is living at home longer. 1 As a result, residential aged care facilities (RACFs) are providing care for significantly older and more complex patients. 1 Australian studies have shown that 95% of residents are taking five or more medications, with the average number of medications taken identified as ranging between 7 and 10. 1 This population is at high risk of adverse drug reactions, which increase with the number of medications used. 1, 2 Patients are also threefold more likely to experience an adverse drug reaction upon first being admitted to an RACF compared with other residents. 2 Medication-related morbidity and mortality in RACFs within the US costs US $7.6 billion annually, and healthcare resources used in the treatment of medication related problems cost US $1.33 for every dollar spent on medications. 3 The pressures faced by the Australian healthcare system have resulted in patients often being less medically stable upon hospital discharge. 1 Furthermore, Australian studies have reported that an average of five to seven medication changes occur during hospitalisation, including two to three medications being ceased and three to four new medications initiated. 4 Patients discharged from hospital to an RACF are at risk of medication-related problems due to a number of factors, including: transfer of patients after hours; prescription of multiple medications; multiple prescribers ordering medications; a lack of or poor quality transfer discharge medication information; delays in the supply of medication in the required format (often a dose administration aid); and an absence of accurate medication charts available to the nurses at the RACF on patient discharge. 1, [4] [5] [6] [7] Australian studies have demonstrated that medication administration errors occur in 20% of patients discharged from hospital to the RACF. 1 More than 60% of patients discharged to an RACF do not have a current medication chart and up to 40% do not have new medications available in time for their first scheduled dose. 8 Elliott et al. 8 demonstrated that 3.9% of medications were missed or significantly delayed in patients with an up-to-date medication chart, compared with 24.8% in those with no up-to-date medication chart. These findings are supported by a study conducted in the US that demonstrated that 3.4 medications per patient were omitted or delayed for an average of 12.5 h on discharge to an RACF. 7 Withholding medications, administering medications without a medication chart or using the medication chart created prior to hospital admission have been identified as common workarounds used by nursing staff in the absence of an accurate up-to-date medication chart. 7 In some cases, these workarounds have been shown to contribute to medication-related errors. 6 Lack of medication supply on transfer to the RACF has been shown to result in unplanned hospital readmissions. 7 Discrepancies between the discharge medication summary and prescription have also been reported in 80% of cases. 7 The risk of inadequate handover of information during this transition is also increased by patients often being unable to participate in the discharge process. 9 Poor-quality transitions of care, including inconsistencies with medications, have been linked to adverse health outcomes. 9 The present systematic review was performed to investigate interventions to improve continuity of medication management when discharging a patient from hospital to an RACF.
METHODS
The procedure and reporting of this systematic review adhere to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. 10 The literature search aimed to identify studies that involved interventions focused on improving the continuity of medication management upon discharge of patients from hospital to an RACF or similar facility (e.g.
long-term care facility, skilled nursing facility, nursing home). Interventions were defined as a communication tool or a service that was initiated by any healthcare professional involved in the discharge process. The interventions also needed to focus on continuity of medication management or processes that would reasonably contribute to this outcome. Discharging from hospital included patient discharges from emergency departments or inpatient units to an RACF or similar facility. Identified studies were included if they were published in English and if there were no exclusion criteria. Studies were excluded if they did not meet all the eligibility criteria, if they had a qualitative, observational or systematic review study design or if the abstract or full-text article were not available despite application of a systematic searching methodology. Relevant studies were selected by searching Embase (1966-), PubMed, The Cochrane Database of Systematic Reviews (1996-), Google Scholar and the Informit Health Collection (1977-) to March 2018. A grey literature search, involving a broader Google search, and hand search of the reference lists of the included studies was then undertaken. The full search strategy is given in Appendix 1. Duplicates were removed, and then the two reviewers independently screened the titles, abstracts and full text for any relevant studies. Disagreements in assignation between the two reviewers were resolved using a consensus approach at each stage in the review process.
The two reviewers independently abstracted data from the selected studies using a data abstraction form created in Excel (Microsoft Excel, Bellevue, WA, USA). The data included author, year, country, objective/s, setting, study design, comparator group, study size and duration, population, mean age (years), gender (per cent female), inclusion criteria, exclusion criteria, target population clearly defined (yes/no), primary end point/s, secondary end point/s, follow-up period, design bias, selection bias, measurement bias, observer bias, response bias and the National Health and Medical Research Council (NHMRC) evidence grade.
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RESULTS
The search strategy identified a total of 1951 studies, 31 from Embase, 1631 from PubMed, 30 from The Cochrane Database, 226 from Google Scholar, 9 from the Informit Health Collection and 24 from the grey literature and hand-search. Of these, seven studies met the inclusion criteria. The study selection process is shown in Figure 1 and the included studies are summarised in Table 1. Crotty et al. 2 performed a randomised single-blinded controlled trial that assessed the effect of a pharmacist transition coordinator on the continuity of medication management upon transfer of patients from hospital to an RACF. The intervention involved a medication transfer summary highlighting changes to medication produced by the transition pharmacist and endorsed by the hospital doctor. This was then faxed to the community pharmacy and general practitioner (GP). After discharge, the pharmacist coordinated a home medicines review conducted by the community pharmacist within 10-14 days after discharge. A case conference between the transition pharmacist, community pharmacist, GP and an RACF nurse was arranged to discuss medication use and appropriateness 14-28 days after discharge. The medication appropriateness index (MAI) was used to assess the quality of prescribing. At baseline, there was no significant difference in mean MAI between the intervention (n = 56) and control (n = 54) groups with values of 3.2 (95% confidence interval (CI) 1.8-4.6) vs 3.7 (95% CI 2.2-5.2), respectively. After intervention, the MAI was significantly lower in intervention than control group (2.5 (95% CI 1.4-3.7) vs 6.5 (95% CI 3.9-9.1), respectively; p = 0.007), demonstrating an improvement in the quality of prescribing.
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The prospective pre-(n = 202) and post-intervention (n = 226) cohort study by Elliott et al. 7 investigated the effect of the addition of a hospital pharmacist-prepared interim residential care medication administration chart (IRCMAC) to the normal discharge procedure. Provision of a 7-day IRCMAC, a photocopy of the prescription and instructions for IRCMAC use were sent to the RACF. This process also included a telephone call by the pharmacist to the RACF notifying them of the process prior to discharge. The results showed a statistically significant 15.6% reduction (95% CI 9.5-21.9%; Moore et al. 9 conducted a prospective cohort study comparing outcomes of usual care (n = 148) with care involving post-discharge videoconferences (n = 214). These bidirectional videoconferences involved discussions between a multidisciplinary hospital team (including a pharmacist, social worker, hospitalist facilitator and project manager) and skilled nursing facility care teams (including nurses, doctors and occasionally physical therapists). The intervention group had lower rates of readmission and a reduced skilled nursing facility length of stay (odds ratio (OR) 0.57 (95% CI 0.34-0.96; p = 0.034) and mean estimate À5.52 days (95% CI À9.61, À1.43; p = 0.01)) compared with the usual care group. There was no significant difference in 30-day mortality between the intervention and standard-care groups. However, a reduction in 30-day total healthcare costs was demonstrated in the intervention group (mean estimate ÀUS $2602.19 per patient; 95% CI ÀUS $4133.90, ÀUS $1070.48; p ≤ 0.001). On the basis of previously published medication reconciliation data, 13 it was postulated that a reduction in medication errors was responsible for the reduced readmissions. 9 Boockvar et al.
14 performed a cohort intervention study with a pre-test (n = 81) and post-test (n = 87) evaluation of outcomes centred on a multidisciplinary team (MDT) intervention aimed at improving continuity of medication management. The MDT first identified residents returning to the RACF; then, the pharmacist reconciled the patient's medications prior to discharge using a communication form to communicate any medication changes to the GP. The GP reviewed the communication form for the RACF to use as a pharmacy record. Ten discrepancy-related adverse drug events (ADE) occurred before the intervention and one occurred after the intervention (relative risk 0.16; 95% CI 0.02-1.2). After adjusting for baseline ADE risk, the odds of a discrepancy-related ADE were significantly lower in the post-intervention group (OR 0.11; 95% CI 0.01-1.0; p = 0.05). The most common discrepancyrelated ADE was new or increased pain from the omission of analgesics. The mean number of medication discrepancies identified through the medication reconciliation process was 6.4, and GPs responded to 85.9% of the total number of discrepancies identified. 14 The cohort intervention study with pre-test (n = 1893) and post-test (n = 87) evaluation of outcomes by Lu et al. 15 involved a coordinated multidisciplinary process based on the principles of lean methodology aimed at reducing medication-related errors to improve continuity of medication management. As part of this process, the pharmacist conducted a medication reconciliation on the discharge medications ordered on the electronic medical record by the hospital doctor, communicating any discrepancies with the hospital doctor so that any corrections could be made prior to discharge. After pharmacist intervention, the proportion of patients discharged with at least one medication error was reduced from 70 to 0% (p-value not reported). For the aggregate of cases categorised as being of minor, moderate or major severity (less than extreme severity), a non-significant 43.2% reduction in risk of 30-day related readmission rates was found (p = 0.1180). Extreme severity of illness was excluded because there was no statistically significant difference shown in readmission rates between these two groups. The authors postulated that this patient population would have likely been readmitted regardless of any medication reconciliation intervention. 15 The cohort intervention study with pre-and post-test evaluation of outcomes by Midlov et al. 16 consisted of three intervention phases, all aimed at reducing medication-related errors to improve continuity of medication management. The first study period (n = 39) involved the standard discharge procedure, whereby a hospital doctor created a discharge information form including general information, a medication report describing any changes that occurred and a medication list, all to be sent to the GP and RACF on the day of discharge. The second study period (n = 53) involved a pharmacist conducting a medication reconciliation and communicating any discrepancies with the hospital doctor prior to discharge. The third study period (n = 31) involved the hospital doctor, with the support of a clinical pharmacist, ensuring that the prescription in the specific medication dispensing system (ApoDos) was accurate prior to discharge. The mean number of medication errors per person during Periods 1, 2 and 3 was 1.5, 1.1 and 0.5, respectively. The only statistically significant differences were found between Periods 1 and 3 (p = 0.048) and between Periods 2 and 3 (p = 0.037). 16 Ward et al. 5 conducted a cohort intervention study to investigate differences between pre-intervention (n = 10) and post-intervention (n = 10) discharge processes aimed at improving the continuity of medication management. The intervention involved the use of an RACF-specific form used by the hospital doctor. This form was then faxed directly to the RACF rather than being sent with the patient. After obtaining approval from the GP, the nursing staff then faxed the form to the community pharmacy prior to receiving the patient, rather than after, to organise the supply of medications and optimise continuity of medications. A non-significant difference in the time from patient arrival at the RACF and administration of first dose of an ordered medication was shown between the post-and pre-intervention groups (15.6 vs 9.4 h, respectively). A significant proportion of patients experienced medication omissions 2012 Elliott et al.:
7 prospective pre-and post-intervention cohort study III-2 Tran et al.:
6 Mixed-methods cohort study with retrospective assessment of hospitalbased elements and prospective follow-up Moore et al. 9 
2017
Prospective cohort intervention study with matched controls III-2 Boockvar et al. 14 
2006
Cohort intervention study with pre-and post-test evaluation of outcomes III-3 Lu et al. 15 
2013
Cohort intervention study with pre-and post-test evaluation of outcomes IV Midlov et al. 16 
2012
Cohort intervention study with pre-and post-test evaluation of outcomes IV Ward et al. Level II, a randomised controlled trial; Level III-1, a pseudo randomised controlled trial; Level III-2, a comparative study with concurrent controls; Level III-3, a comparative study without concurrent controls; Level IV, a case series with either post-test or pre-and post-test outcomes.
between the pre-and post-intervention groups (70 and 100%, respectively; p ≤ 0.05).
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DISCUSSION
To ensure continuity of medication management upon patient discharge from hospital to the RACF, the community healthcare team requires the following: (1) medications supplied in the required format, ideally in an appropriate dose administration aid; (2) access to an accurate up-to-date medication administration chart or order; and (3) access to comprehensive and accurate discharge medication information. 1, 6, 8 Studies have shown that medication-related problems, and in some cases unplanned hospital readmissions, occur when access to these essential requirements is delayed or absent. 1, [4] [5] [6] [7] 9 Heterogeneity of study methodology and outcome measures precluded meta-analysis of the study results. The Level II study found that the implementation of a pharmacist transition coordinator improved the quality of prescribing. 2 The Level III-2 MedGap study including the studies by Elliott et al. 7 and Tran et al. 6 involved the provision of an RACF-specific medication administration chart. The intervention demonstrated a reduction in the number of doses missed or delayed and the number of medication charts requiring a locum service to rewrite or update. 7 It also demonstrated that these medication administration charts were being accurately produced upon discharge and received at the RACF. 6 The other Level III-2 study by Moore et al. 9 involved the implementation of a post-discharge, bidirectional multidisciplinary videoconference to facilitate patient review, including review of medications. The intervention demonstrated a reduction in readmission rates, length of skilled nursing facility length of stay and healthcare costs. 9 All Level III-3 and IV studies involved the provision of discharge medication information, but the study of Ward et al. 5 was the only one that did not involve pharmacist-led medication reconciliation. showed a non-significant increase in the time taken to administration of the first dose and a significant increase in the number of medication omissions. Perhaps this negative study finding could be attributed to the absence of hospital pharmacist involvement in transition coordination of medication supply within the intervention.
There was heterogeneity within the study findings among the interventions used. MDTs were used in all the included studies in an attempt to improve medication management on discharge of patients to RACFs. 2, [5] [6] [7] 9, [14] [15] [16] This is by no means a revolutionary concept, because MDTs have been shown in the past to be a vital factor in effective and safe discharge planning. [17] [18] [19] [20] All the interventions were focused on providing medication information on discharge, 2,5-7,9,14-16 but only two studies also attempted to provide RACF nursing staff with a medication administration chart. [5] [6] [7] The studies of Crotty et al. 2 and Moore et al. 9 were the only two to include the addition of case conferences after discharge, involving medication review. 2, 9 Pharmacists were involved in the discharge process at various stages in the patient's discharge journey in all the studies. 2, [5] [6] [7] 9, [14] [15] [16] Medication reconciliation, by a hospital pharmacist, played a fundamental role in all interventions, 2,6,7,9,14-16 except the intervention implemented by Ward et al. 5 In that case, the involvement of the pharmacist was limited to supply of medications by the community pharmacist. 5 The implementation of medication reconciliation at transitions in care has been reported in studies to reduce medication errors by 50-94% and, more importantly, reduce those medication errors with the potential to cause harm by more than 50%. 21 Improved patient outcomes and a trend for reduced hospital readmissions have also been associated with medication reconciliation processes. 21 No study attempted to address all the barriers demonstrated in the literature to increase the risk of medication-related problems and unplanned hospital readmissions on discharge of patients to the RACF, including: (1) the availability of appropriate staff at the time of discharge to facilitate continuity of medication, such as the hospital and community pharmacist; (2) provision of medication administration handover to ensure that it is clear which medications have been administered prior to discharge and which still require administration; and (3) ensuring the RACF nursing staff have access to medications supplied in the required format and access to an accurate up-to-date medication administration chart or order. 1, [4] [5] [6] [7] Future studies should consider implementation of interventions that more comprehensively address all the barriers discussed. Development of such interventions may be better enabled with the introduction of an electronic health record, with the ability to directly share medication information available to and used by all healthcare professionals involved in this transition of care. Currently, there is minimal use of electronic medication management systems, with the ability to directly share medication data between all care providers remaining rare to date. 1 Critical analysis of the included studies uncovered many limitations. The potential for sampling bias was apparent in all studies, [5] [6] [7] 9, [14] [15] [16] except in that of Crotty et al. 2 involving randomisation. There was potential for selection bias in all of the studies included. 2, [5] [6] [7] 9, [14] [15] [16] Exclusion of patients discharged through other programs, in <24 h from admission, and outside of pharmacy operating hours were common themes with the potential to introduce selection bias. 2, 6, 7, 14, 15 The method of selection was not clearly described in some cases. 5, 9, 15, 16 There was a potential for measurement bias in all studies except the substudy by Tran et al. 6 within the MedGap study and the study by Moore et al.
9
. 
CONCLUSION
The high risk of medication-related problems demonstrated upon discharge of patients from hospital to an RACF is multifaceted. No single intervention has been demonstrated to successfully address all barriers encountered during this transition in care. However, it is clear that a multidisciplinary approach, including medication reconciliation conducted by a pharmacist, is vital to improving continuity of medication management. Interventions addressing all barriers impeding continuity of medication management during this transition of care should be explored further.
